NZ596823A - Swine influenza hemagglutinin variants - Google Patents
Swine influenza hemagglutinin variantsInfo
- Publication number
- NZ596823A NZ596823A NZ596823A NZ59682310A NZ596823A NZ 596823 A NZ596823 A NZ 596823A NZ 596823 A NZ596823 A NZ 596823A NZ 59682310 A NZ59682310 A NZ 59682310A NZ 596823 A NZ596823 A NZ 596823A
- Authority
- NZ
- New Zealand
- Prior art keywords
- influenza
- disclosed
- population
- host cells
- reassortant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ617191A NZ617191A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22042609P | 2009-06-25 | 2009-06-25 | |
| US22798609P | 2009-07-23 | 2009-07-23 | |
| US23402109P | 2009-08-14 | 2009-08-14 | |
| US25889009P | 2009-11-06 | 2009-11-06 | |
| PCT/US2010/039826 WO2010151673A1 (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ596823A true NZ596823A (en) | 2013-11-29 |
Family
ID=43386887
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ617191A NZ617191A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
| NZ596823A NZ596823A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ617191A NZ617191A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8088393B2 (enExample) |
| EP (1) | EP2448598B1 (enExample) |
| JP (1) | JP5745511B2 (enExample) |
| KR (1) | KR20120101318A (enExample) |
| CN (1) | CN102802666B (enExample) |
| AU (2) | AU2010266078B2 (enExample) |
| BR (1) | BRPI1014844A2 (enExample) |
| CA (1) | CA2766377A1 (enExample) |
| MX (1) | MX2012000123A (enExample) |
| NZ (2) | NZ617191A (enExample) |
| RU (1) | RU2560420C2 (enExample) |
| SG (2) | SG176178A1 (enExample) |
| WO (1) | WO2010151673A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010151673A1 (en) | 2009-06-25 | 2010-12-29 | Medimmune, Llc | Swine influenza hemagglutinin variants |
| HK1200845A1 (en) * | 2011-10-07 | 2015-08-14 | Medimmune, Llc | Influenza hemagglutinin variants |
| KR101315273B1 (ko) * | 2012-10-29 | 2013-10-08 | 대한민국 | 강독화된 인플루엔자 바이러스 변이주 |
| CA2893429A1 (en) * | 2012-12-03 | 2014-06-12 | Synthetic Genomics Vaccines, Inc. | Influenza virus reassortment |
| PT3142750T (pt) * | 2014-05-13 | 2020-09-22 | Univ Pennsylvania | Composições que compreendem aav expressando construções de anticorpos duplos e suas utilizações |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| MA48852A (fr) | 2015-05-13 | 2020-04-01 | Univ Pennsylvania | Expression médiée par aav d'anticorps anti-grippaux et leurs procédés d'utilisation |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2018160573A1 (en) | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Influenza vaccines based on aav vectors |
| JOP20190200A1 (ar) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
| WO2018160582A1 (en) | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
| MX2020006530A (es) | 2017-12-22 | 2020-10-15 | Codagenix Inc | Virus recombinante con region desoptimizada de par de codones y usos del mismo para el tratamiento de cancer. |
| CA3091508A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| WO2025081053A1 (en) * | 2023-10-11 | 2025-04-17 | Flugen, Inc. | Formulations for thermostable vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| JP5349049B2 (ja) * | 2005-10-17 | 2013-11-20 | メディミューン，エルエルシー | インフルエンザウイルス製造用マルチプラスミド系 |
| JP2010500034A (ja) * | 2006-08-09 | 2010-01-07 | メッドイミューン バクシーンズ，インコーポレイティド | インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体 |
| EP2160198A2 (en) * | 2007-05-31 | 2010-03-10 | Statens Serum Institut | Influenza vaccines |
| WO2010151673A1 (en) | 2009-06-25 | 2010-12-29 | Medimmune, Llc | Swine influenza hemagglutinin variants |
-
2010
- 2010-06-24 WO PCT/US2010/039826 patent/WO2010151673A1/en not_active Ceased
- 2010-06-24 CA CA2766377A patent/CA2766377A1/en not_active Abandoned
- 2010-06-24 JP JP2012517731A patent/JP5745511B2/ja not_active Expired - Fee Related
- 2010-06-24 SG SG2011085669A patent/SG176178A1/en unknown
- 2010-06-24 NZ NZ617191A patent/NZ617191A/en not_active IP Right Cessation
- 2010-06-24 EP EP10792667.7A patent/EP2448598B1/en not_active Not-in-force
- 2010-06-24 RU RU2012102385/10A patent/RU2560420C2/ru not_active IP Right Cessation
- 2010-06-24 BR BRPI1014844A patent/BRPI1014844A2/pt not_active IP Right Cessation
- 2010-06-24 CN CN201080027726.4A patent/CN102802666B/zh not_active Expired - Fee Related
- 2010-06-24 AU AU2010266078A patent/AU2010266078B2/en not_active Ceased
- 2010-06-24 MX MX2012000123A patent/MX2012000123A/es not_active Application Discontinuation
- 2010-06-24 KR KR1020127000803A patent/KR20120101318A/ko not_active Ceased
- 2010-06-24 US US12/822,781 patent/US8088393B2/en not_active Expired - Fee Related
- 2010-06-24 NZ NZ596823A patent/NZ596823A/xx not_active IP Right Cessation
- 2010-06-24 SG SG10201403557QA patent/SG10201403557QA/en unknown
-
2011
- 2011-12-01 US US13/308,809 patent/US8715691B2/en not_active Expired - Fee Related
-
2014
- 2014-06-25 AU AU2014203458A patent/AU2014203458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP5745511B2 (ja) | 2015-07-08 |
| AU2010266078A1 (en) | 2011-12-22 |
| RU2560420C2 (ru) | 2015-08-20 |
| RU2012102385A (ru) | 2013-07-27 |
| AU2010266078B2 (en) | 2014-08-14 |
| CN102802666A (zh) | 2012-11-28 |
| US20110123559A1 (en) | 2011-05-26 |
| KR20120101318A (ko) | 2012-09-13 |
| US8715691B2 (en) | 2014-05-06 |
| EP2448598A4 (en) | 2013-10-23 |
| CN102802666B (zh) | 2015-06-03 |
| US8088393B2 (en) | 2012-01-03 |
| NZ617191A (en) | 2015-06-26 |
| US20120244600A1 (en) | 2012-09-27 |
| EP2448598A1 (en) | 2012-05-09 |
| WO2010151673A1 (en) | 2010-12-29 |
| SG10201403557QA (en) | 2014-10-30 |
| EP2448598B1 (en) | 2016-03-30 |
| SG176178A1 (en) | 2011-12-29 |
| JP2012531205A (ja) | 2012-12-10 |
| MX2012000123A (es) | 2012-03-07 |
| CA2766377A1 (en) | 2010-12-29 |
| AU2014203458A1 (en) | 2014-07-17 |
| BRPI1014844A2 (pt) | 2019-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ596823A (en) | Swine influenza hemagglutinin variants | |
| JP7627911B2 (ja) | 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス | |
| EP2493912B1 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
| JP2012531205A5 (enExample) | ||
| PH12021550029A1 (en) | Adenovirus-vectored vaccine for preventing sars-cov-2 infection | |
| JP2015119730A5 (enExample) | ||
| WO2017191264A1 (en) | Nucleic acid molecules and uses thereof | |
| BRPI0719469C1 (pt) | vetores de expressão derivados de retrovírus e métodos para produzir um vírus infeccioso de sarampo | |
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2019527055A5 (enExample) | ||
| JP2014534202A5 (enExample) | ||
| JP2017522907A5 (enExample) | ||
| TN2011000628A1 (en) | Production of polio virus at high titres for vaccine production | |
| RU2014129788A (ru) | Вакцины против hpv | |
| AU2016355468A1 (en) | CMV vectors comprising microRNA recognition elements | |
| RU2015118580A (ru) | НОВЫЙ ВЫСОКО ФУНКЦИОНАЛЬНЫЙ ФЕРМЕНТ, ИМЕЮЩИЙ МОДИФИЦИРОВАННУЮ СУБСТРАТНУЮ СПЕЦИФИЧНОСТЬ β-ГЕКСОЗАМИНИДАЗЫ ЧЕЛОВЕКА И ПРОЯВЛЯЮЩИЙ УСТОЙЧИВОСТЬ К ПРОТЕАЗЕ | |
| RU2011142793A (ru) | Полученная из микроорганизма протеаза усовершенствованного типа, обеспечивающая свертывание молока | |
| RU2014116371A (ru) | Повышение выхода вирусоподобных частиц в растениях | |
| RU2011133057A (ru) | Стабильный вектор конститутивно высокой экспрессии для получения вакцины против впч и трансформированные этим вектором рекомбинантные молочнокислые бактерии | |
| CN105154436A (zh) | 包含突变的核酸内切酶识别区dna及其基因组编辑应用 | |
| RU2018130683A (ru) | Аттенуированный вирус инфекционного бронхита | |
| RU2014140731A (ru) | Варианты гемагглютинина и нейраминидазы гриппа | |
| JP2012517239A5 (enExample) | ||
| WO2022219607A1 (en) | Codon-optimized nucleotide sequences encoding a coronavirus spike protein and uses thereof | |
| WO2008058752A3 (en) | Lentiviral vectors for gene transfer in quiescent (g0) cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 24 JUN 2017 BY HENRY HUGHES Effective date: 20140521 |
|
| LAPS | Patent lapsed |